Boyd D. Obermeyer
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Antibiotics Pharmacokinetics and Efficacy
- Cannabis and Cannabinoid Research
- Treatment of Major Depression
- Psychiatry and Mental health top 10%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
Papers in
-
- Antibiotics Pharmacokinetics and Efficacy 6
- Pharmacogenetics and Drug Metabolism 3
- Co-authors
- Louis Lemberger (3 shared papers)Anthony Murphy (1 shared paper)David E. Tupper (1 shared paper)Todd A. Gillespie (1 shared paper)Edward L. Mattiuz (1 shared paper)Kelem Kassahun (1 shared paper)John T. Callaghan (5 shared papers)Alan Rubin (5 shared papers)
- Journals
- Clinical Pharmacology & Therapeutics (6 papers)Clinical Chemistry (1 paper)Scandinavian Journal of Gastroenterology (1 paper)Antimicrobial Agents and Chemotherapy (1 paper)Toxicology and Applied Pharmacology (1 paper)
- Partner nations
- United StatesSingaporeSwitzerland
In The Last Decade
Boyd D. Obermeyer
15 papers receiving 418 citations
Peers
Comparison fields: 5 of 91
- Pharmacology 80
- Psychiatry and Mental health 115
- Pharmacology 131
- Biological Psychiatry 18
- Gastroenterology 27
Countries citing papers authored by Boyd D. Obermeyer
This map shows the geographic impact of Boyd D. Obermeyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boyd D. Obermeyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boyd D. Obermeyer more than expected).
Fields of papers citing papers by Boyd D. Obermeyer
This network shows the impact of papers produced by Boyd D. Obermeyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boyd D. Obermeyer. The network helps show where Boyd D. Obermeyer may publish in the future.
Co-authors
The 25 scholars most cited alongside Boyd D. Obermeyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Disposition and biotransformation of the antipsychotic agent olanzapine in humans. | 1997 | 188 |
| 2 | 1971 | 54 | |
| 3 | 1987 | 42 | |
| 4 | 1977 | 36 | |
| 5 | 1985 | 30 | |
| 6 | 1979 | 26 | |
| 7 | 1987 | 22 | |
| 8 | 1986 | 16 | |
| 9 | 1990 | 15 | |
| 10 | 1981 | 12 | |
| 11 | 1972 | 10 | |
| 12 | 1978 | 8 | |
| 13 | 1990 | 7 | |
| 14 | 1978 | 4 | |
| 15 | 1997 | 2 |
About Boyd D. Obermeyer
Boyd D. Obermeyer is a scholar working on Pharmacology, Pharmacology, Molecular Biology, Organic Chemistry and Pediatrics, Perinatology and Child Health, having authored 15 papers that have together received 472 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Pharmacogenetics and Drug Metabolism (3 papers), Plant and fungal interactions (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Gastroesophageal reflux and treatments (2 papers), Pharmaceutical studies and practices (2 papers), Organic and Inorganic Chemical Reactions (1 paper) and Forensic Toxicology and Drug Analysis (1 paper). The work is most often cited by research in Pharmacology (80 citations), Psychiatry and Mental health (115 citations), Pharmacology (131 citations), Biological Psychiatry (18 citations) and Gastroenterology (27 citations). Boyd D. Obermeyer has collaborated with scholars based in United States, Singapore and Switzerland. Frequent co-authors include Louis Lemberger, Anthony Murphy, David E. Tupper, Todd A. Gillespie, Edward L. Mattiuz, Kelem Kassahun, John T. Callaghan, Alan Rubin, Robert L. Wolen and Richard F. Bergstrom. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Clinical Chemistry, Scandinavian Journal of Gastroenterology, Antimicrobial Agents and Chemotherapy and Toxicology and Applied Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.